AXON vs FERG

AXON's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to both the Graham Number ($52.48) and intrinsic value ($22.33), supported by strong revenue growth (30.6% YoY) and consistent earnings beats, though recent negative EPS growth and insider selling raise concerns. Profitability is mixed with a healthy gross margin (60.36%) but negative operating and asset returns (ROA: -0.03%, Operating Margin: -0.23%). Analysts maintain a 'buy' recommendation with a $815 target, implying 33% upside, but insider sentiment is bearish, and technical trend is neutral to weak.

FERG presents a dichotomy between strong operational execution and stretched valuation. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the Graham Number of $82.81 suggests the stock is trading at a significant defensive premium. Despite a strong track record of earnings beats and a sustainable dividend payout, the bearish technical trend (10/100) and weak insider sentiment (40/100) suggest a potential near-term ceiling. The stock is currently trading slightly above its growth-based intrinsic value of $249.18.